Since 2019, Fleming Fund grantee, International Vaccine Institute (IVI), has led the CAPTURA consortium to expand the volume of historical data for antimicrobial resistance (AMR), consumption (AMC), and use (AMU) across 12 countries in South and Southeast Asia.
Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia (CAPTURA) project announced.
The Regional Grant for South Asia and South East Asia has been awarded to an International Vaccine Institute led consortium to undertake the CAPTURA project.
An international consortium, led by the International Vaccine Institute (IVI), has been awarded the a Fleming Fund Regional Grant from round one. The grant has been awarded to conduct the Capturing Data on Antimicrobial Resistance (AMR) Patterns and Trends in Use in Regions of Asia (CAPTURA) project. CAPTURA also includes the Public Health Surveillance Group (PHSG), the Brigham and Women’s Hospital, and the University of Oxford’s Big Data Institute (BDI).
The project will identify gaps in data and areas for quality improvement that can be addressed in future initiatives to strengthen surveillance capacity. Finally, the information resource generated by the project will improve awareness, advocacy, policy, and interventions needed to combat AMR and antimicrobial misuse.
CAPTURA aims to:
- increase the volume of data available to improve spatiotemporal mapping of AMR and antimicrobial use (AMU)
- assess the quality of data and provide meta-data to give regional and inter-regional context
- undertake analysis of the data
- ensure findings are disseminated locally, regionally and globally
While CAPTURA will collaborate with 6 countries in South Asia and 6 countries in South East Asia, a sister project, announced last week, the Mapping Antimicrobial Resistance and Use Partnership (MAAP) Program, will collect similar data on AMR and AMU across 12 African countries.
“IVI’s work with CAPTURA is based on our belief that stronger data will inform better policy and that vaccines have an important role to play combatting AMR.”
Dr. Jerome Kim, the Director General of IVI
“IVI is privileged to lead CAPTURA and collaborate with internationally renowned organizations in AMR to address one of the most pressing challenges in global health.”
Dr. Florian Marks, program director at IVI
More Like This
Report contains key findings for stakeholders engaging in AMR surveillance, research, policy, regulatory decision-making, and other infectious disease prevention and control programmes in Bangladesh and wider Asia, supported by the Fleming Fund.